Longevity Health Holdings Inc.
XAGE - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$274.76K
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $274,761.00 |
|---|---|
| Enterprise Value | $561,235.00 |
| Earnings per Share | $-4.01 |
| Beta | 0.43 |
| Outstanding Shares | 2,475,321 |
Return
| Return on Equity | 78.49% |
|---|---|
| Return on Assets | -647.05% |
| Return on Invested Capital | 49.62% |
Valuation & Multiples
| P/E Ratio | -0.03 |
|---|---|
| PEG | 18.74 |
| Price to Sales | - |
| Price to Book Ratio | -0.03 |
| Enterprise Value to Revenue | 0.33 |
| Enterprise Value to EBIT | -0.13 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.57 |
| Debt to Equity | -0.04 |
Revenue Sources
No data
Last Earnings Call
Report Date
August 14, 2026
EPS Estimate
-
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateInstitutional Put/Call Ratio
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.57%▼ 0.17% |
|---|---|
| Total Invested | $3,680▼ 11.22% |
| Investors Holding | 10% |
About Longevity Health Holdings Inc.
15 employees
CEO: Mr. Rajiv Sarman Shukla
Longevity Health Holdings Inc focuses on the development of plasma-based bioactive material (PBM) to stimulate tissue repair or growth after injury, disease, and aging. Its lead product candidate is CT-101 bone healing accelerant for tib...